Pulmonary Thromboembolism after Intravenous Immunoglobulin Therapy in Guillain-Barre Syndrome.
10.14253/kjcn.2016.18.1.14
- Author:
Jin Mo PARK
1
;
Nam Kyun KIM
;
Jin Sung PARK
Author Information
1. Department of Neurology, Dongguk University, School of Medicine, Gyeongju, Korea.
- Publication Type:Case Report
- Keywords:
Guillain-Barre syndrome;
Intravenous immunoglobulin;
Pulmonary thromboembolism
- MeSH:
Dyspnea;
Female;
Guillain-Barre Syndrome*;
Humans;
Immunization, Passive*;
Immunoglobulins*;
Immunoglobulins, Intravenous;
Middle Aged;
Nervous System Diseases;
Pulmonary Embolism*
- From:Korean Journal of Clinical Neurophysiology
2016;18(1):14-17
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Intravenous immunoglobulin (IVIG) is a safe treatment to treat various neurological disorders, but fatal thrombotic events as rare complications have been reported. A 54-year-old woman with Guillain-Barre syndrome complained of dyspnea during IVIG treatment. She was finally diagnosed with pulmonary thromboembolism. To the best of our knowledge, this is the first case of pulmonary thromboembolism associated with IVIG treatment in a Korean patient with Guillain-Barre syndrome.
